Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Trends of prevalence of primary HIV drug resistance in Germany.

The Journal of antimicrobial chemotherapy - 1 Oct 2007

Sagir Abdurrahman, Oette Mark, Kaiser Rolf, Däumer Martin, Fätkenheuer Gerd, Rockstroh Jürgen Kurt, Knechten Heribert, Schmutz Günther, Hower Martin, Emmelkamp Jetske, Pfister Herbert, Häussinger Dieter

Abstract excerpt

BACKGROUND: Primary HIV drug resistance (PDR) is associated with poor treatment outcome of first-line highly active antiretroviral therapy (HAART). The aim of the study was to observe the trend of prevalence of PDR between 2001 and 2005. METHODS: In a prospective multicentre study in the state of Nordrhein-Westfalen, Germany, 831 treatment-naive chronically HIV-infected patients underwent genotypic resistance...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Germany
Share to HIV

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to Ethnicity

Share to Genome, Viral

Share to Genotype

Share to HIV Infections

Share to Sexual Behavior

Source

Identifiers

PMID: 17715124
DOI: 10.1093/jac/dkm274

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Trends of prevalence of primary HIV drug resistance in Germany.PMID 17715124Read ↗

[Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].Semantic proximity Read ↗

French National Sentinel Survey of Antiretroviral Drug Resistance in Patients With HIV-1 Primary Infection and in Antiretroviral-Naive Chronically Infected Patients in 2001-2002Semantic proximity Read ↗

Transmitted drug resistance and subtype patterns of viruses from reported new HIV diagnoses in Germany, 2017-2020.Semantic proximity Read ↗

Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France.Semantic proximity Read ↗

Epidemiology of transmitted drug resistance in chronically HIV-infected patients in Germany: the RESINA study 2001-2009.Semantic proximity Read ↗

HIV primary drug resistance and associated HIV risk factors among HIV positive blood donors in Brazil from 2007 to 2017.Semantic proximity Read ↗

Ten years survey of primary HIV-1 resistance in Serbia: the occurrence of multiclass resistance.Semantic proximity Read ↗

Primary drug-resistance in HIV-positive patients on initiation of first-line antiretroviral therapy in Germany.Semantic proximity Read ↗

Prevalence of primary antiretroviral resistance: trends in Korea.Semantic proximity Read ↗

The incidence rate of HIV type-1 drug resistance in patients on antiretroviral therapy: a nationwide population-based Danish cohort study 1999-2005.Semantic proximity Read ↗

Trends in antiretroviral therapy and prevalence of HIV drug resistance mutations in Sweden 1997-2011.Semantic proximity Read ↗

[Investigation of HIV-1 primary drug resistance mutations in antiretroviral therapy-naive cases].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.